Susquehanna International Group’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-175,223
| Closed | -$3.33M | – | 5413 |
|
|
2019
Q1 | $3.33M | Buy |
175,223
+26,435
| +18% | +$502K | ﹤0.01% | 587 |
|
|
2018
Q4 | $2.01M | Buy |
148,788
+11,490
| +8% | +$155K | ﹤0.01% | 952 |
|
|
2018
Q3 | $1.52M | Buy |
+137,298
| New | +$1.52M | ﹤0.01% | 1147 |
|
|
2017
Q1 | – | Sell |
-47,645
| Closed | -$234K | – | 5233 |
|
|
2016
Q4 | $234K | Buy |
47,645
+36,429
| +325% | +$179K | ﹤0.01% | 3621 |
|
|
2016
Q3 | $56K | Buy |
+11,216
| New | +$56K | ﹤0.01% | 2765 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 4840 |
|
|
2016
Q1 | – | Sell |
-80,611
| Closed | -$837K | – | 4975 |
|
|
2015
Q4 | $837K | Buy |
80,611
+37,091
| +85% | +$385K | ﹤0.01% | 2507 |
|
|
2015
Q3 | $804K | Sell |
43,520
-51,905
| -54% | -$959K | ﹤0.01% | 2656 |
|
|
2015
Q2 | $1.86M | Sell |
95,425
-46,386
| -33% | -$903K | ﹤0.01% | 1956 |
|
|
2015
Q1 | $2.49M | Sell |
141,811
-86,744
| -38% | -$1.52M | ﹤0.01% | 1440 |
|
|
2014
Q4 | $3.66M | Buy |
228,555
+200,491
| +714% | +$3.21M | ﹤0.01% | 1281 |
|
|
2014
Q3 | $353K | Sell |
28,064
-54,858
| -66% | -$690K | ﹤0.01% | 3152 |
|
|
2014
Q2 | $1.3M | Buy |
82,922
+6,503
| +9% | +$102K | ﹤0.01% | 2156 |
|
|
2014
Q1 | $1M | Sell |
76,419
-32,966
| -30% | -$433K | ﹤0.01% | 2085 |
|
|
2013
Q4 | $1.76M | Buy |
109,385
+84,660
| +342% | +$1.36M | ﹤0.01% | 1756 |
|
|
2013
Q3 | $411K | Sell |
24,725
-23,615
| -49% | -$393K | ﹤0.01% | 2746 |
|
|
2013
Q2 | $487K | Buy |
+48,340
| New | +$487K | ﹤0.01% | 2534 |
|